Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 220

Posts Tagged ‘laboratory’

Global & China Laboratory Digestion Systems Market

Posted by fidest press agency su sabato, 28 dicembre 2019

The “Laboratory Digestion Systems Market Insights 2019, Analysis and Forecast Global and Chinese Market to 2024, by Manufacturers, Product Type, Application, Regions and Technology” report has been added to ResearchAndMarkets.com’s offering.
Laboratory Digestion Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Laboratory Digestion Systems industry with a focus on the Chinese market. The report provides key statistics on the market status of the Laboratory Digestion Systems manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Laboratory Digestion Systems market covering all important parameters.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

College of American Pathologists and Seoul National University Host Advanced Education for Doctors and Laboratory Scientists

Posted by fidest press agency su domenica, 17 novembre 2019

In an effort to foster laboratory quality and further advance the evolving field of clinical microbiology, the College of American Pathologists (CAP), in partnership with Seoul National University College of Medicine (SNUCM), will host a daylong educational course for approximately 150 pathologists and laboratory professionals at Seoul National University Hospital (SNUH) Nov. 18.
The event, “Be-All and End-All in Clinical Microbiology,” will feature seven speakers on a variety of topics within the field of medical science that focuses on the study, diagnosis and treatment of infectious diseases.Daniel Rhoads, MD, FCAP, will give three presentations on topics including antimicrobial testing challenges and the rising practice of molecular microbiology testing. He is a member of the CAP Microbiology Committee, which works to provide the most up-to-date expertise and information on emerging technologies and quality assurance in the field.While Dr. Rhoads will be teaching attendees about CAP guidelines and best practices, he also expects to collaborate with and learn from other attendees and presenters at SNUCM’s department of laboratory medicine.
He says, “I always look forward to interacting with pathologists and clinical microbiologists that take care of patients that are a half a world away from me and my patients in Cleveland, Ohio; and I look forward to hearing about the challenges that they are facing and the advancements that will overcome them to help us to help patients.” Taek Soo Kim, MD, assistant professor in the department of laboratory medicine at SNUH and one of the organizers of the event, agrees that advancements in next generation sequencing and mass spectrometry discussed at the Nov. 18 event are ultimately for the good of the patient.To help ensure quality, SNUCM has hosted annual workshops for the past 30 years, according to Dr. Kim. In addition to educational opportunities, he also cites the laboratory’s CAP accreditation as an important step in maintaining SNUH’s position as a top health care facility.
Dr. Kim says, “As a leading national hospital in Korea, our institution is participating in numerous international clinical trials—CAP accreditation is an assurance that the test results from our laboratory are of high quality.”The CAP has board-certified pathologist members and laboratory professionals from all over the world inspect and accredit more than 8,000 laboratories to ensure quality practices, testing accuracy and safety for patients. It also supplies proficiency testing to over 20,000 laboratories worldwide as a way for them to self-assess their equipment and diagnostic testing performance. The CAP hosts a range of international educational symposiums throughout the year, including an upcoming partnership with the Taiwan Society of Clinical Pathologists in Taipei Nov. 23.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

CAP Laboratory Accreditation Program Expands Inspector Training Footprint in Japan

Posted by fidest press agency su giovedì, 3 ottobre 2019

The College of American Pathologists (CAP) and CGIkk hosted laboratory accreditation inspector training for 20 pathologists from leading institutions across Japan. The September 28 training was the first step in producing more regional inspectors to accredit laboratories on behalf of the CAP, helping to ensure laboratory quality and accuracy for improved patient care. The CAP’s accreditation program is internationally recognized and the largest of its kind that utilizes teams of practicing laboratory professionals as inspectors. During on-site inspections conducted every two years, CAP inspection teams use checklists that represent the CAP accreditation program’s rigorous accreditation standards and cover anatomic pathology, cytopathology, molecular pathology, and the overall management and operation of the medical laboratory along with other disciplines. The CAP updates the checklist annually to reflect the latest in laboratory medicine. For example, the CAP has added molecular pathology guidelines that emphasize next generation sequencing as a leading-edge, extensive analysis to detect genomic changes.After more extensive training sessions and the completion of an exam, the pathologists in Dr. Osamura’s session will begin to conduct onsite inspections of other medical laboratories on behalf of the CAP. He is familiar with the process as his medical laboratory is already CAP accredited. Ten other pathologists in the September 28 training also come from CAP-accredited laboratories. The other 10 participants come from laboratories that will soon be pursuing CAP accreditation and this training will prepare them for that process, which typically takes about one year to complete.Bharati S. Jhaveri, MD, FCAP, and chair of the CAP’s Council on Accreditation, led the training in Tokyo and was excited to work with Japanese pathologists and teach them more about the CAP laboratory accreditation program.The CAP—the world’s largest organization of pathologists certified by the American Board of Pathology—advocates on behalf of their member pathologists through legislative action in the United States and provides a wide range of educational opportunities to pathologists internationally. Its laboratory accreditation and proficiency testing programs help ensure the highest quality and safety practices in the more than 8,000 accredited laboratories throughout the world.Japanese company CGIkk helps clinical laboratories institute and maintain quality management systems through staff education as well as software and information development. They were the first to support and implement CAP accreditation in Japan.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

PPD Expanding Bioanalytical Laboratory Capabilities

Posted by fidest press agency su lunedì, 23 settembre 2019

Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing research needs.The expansion of the lab’s immunochemistry, biomarker and chromatography services builds on PPD’s ongoing investments in its Richmond facilities, which also have included significant previous enhancements to its vaccine sciences, biomarker, genomics and automation services. The current expansion includes growing the lab’s immunochemistry and biomarker space by 8,000 square feet, which will be used for both biomarker lab capacity and a dedicated lab team for one of PPD’s global biopharmaceutical clients.The company anticipates adding some 200 new positions as a result of its continuing expansion at the bioanalytical lab. PPD® Laboratories’ operation in Richmond, elements of which have been in operation since 1985, currently totals more than 250,000 square feet, making it one of the largest bioanalytical labs in the world. Today, the lab employs more than 1,000 people, including Ph.D.-level scientists, analytical laboratory staff and other scientific professionals.Additionally, this month the company plans to begin the process of adding 30,000 square feet of space dedicated to chromatography services. This step will enable PPD to design and build a state-of-the-art facility focusing on modern mass spectrometry and automation and offering a layout optimized for the bioanalysis of complex molecules, such as antibody-drug conjugates, and advanced biotherapeutics, such as cell and gene therapies. Work also is scheduled to begin this month to create a 4,500-square-foot cell lab. This summer, PPD completed the move of administrative staff into 36,000 square feet at One Holland Place.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

“3-Day Training: The ARM Exploit Laboratory”

Posted by fidest press agency su mercoledì, 27 febbraio 2019

The all new ARM IoT Exploit Laboratory is a fast paced 3-day intermediate level class intended for students who want to take their exploit writing skills to the ARM platform. The class covers everything from an introduction to ARM assembly all the way to Return Oriented Programming (ROP) on ARM architectures. Our lab environment features hardware and virtual platforms for exploring exploit writing on ARM based Linux systems and IoT devices.The class concludes with an end-to-end Firmware-To-Shell hack, where we extract the firmware from a popular SoHo router, build a virtual environment to emulate and debug it, and then use the exploit to gain a shell on the actual hardware device.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Applied DNA Expands Internationally with New Central DNA Testing Laboratory in India

Posted by fidest press agency su mercoledì, 24 gennaio 2018

DNAApplied DNA Sciences, Inc. (NASDAQ:APDN, “Applied DNA,” “the Company”) today announced the establishment of a Central DNA Testing Laboratory in Ahmedabad, India providing full forensic authentication services. The laboratory supports Applied DNA’s growing global textile business in the Asia-Pacific region with expansion capability for other supply chains present in the region, such as fertilizer and pharmaceuticals. Officially opening on February 15, 2018, the Central Laboratory is strategically located in the state of Gujarat, an economic hub for the development and advancement of cotton, other textiles, fertilizers, petrochemicals and pharmaceuticals.Dr. Ila Lansky, a forensic scientist with over 11 years of forensic DNA experience, will direct the Central DNA Testing Laboratory. She currently oversees all aspects of forensic analysis, testing, authentication and reporting for all samples submitted, following the standard operating procedures established by Applied DNA’s New York forensic laboratories. The Central DNA Testing Laboratory is a high throughput laboratory, providing customers with accurate reports in a short turnaround time.
“This is an important opportunity for Applied DNA to bring our proven technologies to the heart of India’s textile industry, and share our impeccable standards and operational protocols,” said Dr. Lansky. “The laboratory will have the ability to process thousands of samples, serving our textiles customers in the region.”The Indian textile industry is currently estimated at approximately $135 billion USD and is expected to reach $230 billion by 2023 (IBEF 2017). It is home to such global textile brands and manufacturers as The Himatsingka Group and GHCL Limited. Additionally, India is home to the sixth largest pharmaceutical market in the world, with an expected value of $550 billion by 2020 (IBEF 2017).“Opening a lab in Gujarat has both strategic and practical importance for Applied DNA,” said Dr. James A. Hayward, president and chief executive officer of Applied DNA. “Our partnership with Himatsingka has proven remarkably successful, with uptake in the commercial ecosystem and endorsement by big box retailers. Adoption of our technologies by other textile companies is growing. Working closely with such India-based industry majors as Himatsingka and GHCL, we know Applied DNA’s value in enabling source-verified supplied chains and contributing the steady growth and ensured protection of the circular economy. It only makes sense for Applied DNA to have a facility where so many of our current and future partners are based.”

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Large nuclear cardiology laboratory slashes radiation dose by 60% in eight years

Posted by fidest press agency su domenica, 7 maggio 2017

viennaVienna, Austria. A large nuclear cardiology laboratory has slashed its average radiation dose by 60% in eight years, according to new research presented today at ICNC 2017 and published in JACC: Cardiovascular Imaging.1,2 The study in over 18 000 patients shows dose reductions were achieved despite a large number of obese patients.
“There has been concern amongst the medical community and the public that the radiation from medical diagnostic tests could increase the risk of cancer,” said Professor Randall Thompson, a cardiologist at the Mid America Heart Institute, Kansas City, Missouri, US.
He continued: “Although the risk of harm from an individual nuclear cardiology test is very low – even very conservative estimates suggest only one in 1 000 extra patients would develop cancer 20 years later – the cumulative dose from multiple medical diagnostic tests may be a concern.” Medical societies advocate getting radiation doses as low as is reasonably achievable. There are ways to do this but surveys show that adoption of new technologies, which cost money, and new testing algorithms, which take more physician time, has been slow.
This study assessed the impact on radiation dose of modifying protocols and introducing new hardware (cameras) and post processing software in a large nuclear cardiology laboratory network in Kansas City.The study included the 18 162 single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) studies performed at all four of the Saint Luke’s Mid America Heart Institute nuclear cardiology laboratories from 1 January 2009 to 30 September 2016. SPECT MPI shows how well blood flows through the muscle of the heart and is primarily performed to diagnose the cause of chest pain or to help manage patients with known coronary artery disease. Protocols were modified by performing stress-only tests where possible, which saves the radiotracer dose from the rest scan. Stress and rest scans are still required in some patients since shadowing from body parts can look like a lack of blood flow and two scans can clarify the findings. Technetium tracers are now used instead of thallium 100% of the time at one-third of the radiation dose.Small field of view cameras which have advanced post processing, and a new generation of camera systems which are more sensitive and need less radiotracer injected into the body, have both been introduced. These camera systems are equipped with advanced processing which enhances the nuclear pictures and need less radiation or shorter image acquisition times. Professor Thompson’s laboratory focussed primarily on reducing the radiation dose.
The average radiation dose fell from 17.9 mSv in 2009 to 7.2 mSv in 2016 and the median dose (the 50th percentile) dropped from 10.2 mSv to 2.5 mSv. Professor Thompson said: “There was a dramatic lowering of the radiation dose with all of these concerted efforts. The average dose fell by 60% and the median dropped by 75%.” “The average dose had fallen to 5.4 mSv in 2012 but crept up as we’ve had more obese patients referred in whom we have to use the higher dose protocols,” he added. “But more than half of patients now are tested with a low-dose, stress-only test using the new technology, which is why the median dose of radiation has fallen so dramatically.”
The average background dose for people living in Europe and North America from radon underground and cosmic background sources is about 3 mSv a year. Medical societies consider higher and lower dose tests to be above 10 mSv and below 3 mSv, respectively. In 2010 the American Society of Nuclear Cardiology set a target of 9 mSv or less for the majority of tests. Professor Thompson said: “The majority of studies were in the high dose range back in 2009 and now most tests have a radiation dose that is about a third of the target. This is despite being referred a larger number of obese patients. In the last 2.5 years, 17% of patients have needed the large field of view camera as their average body mass index was 46 kg/m2 and they were simply too big for the small cameras.”He concluded: “By adopting contemporary protocols and technologies it is feasible to substantially lower radiation doses in nuclear cardiology in very large numbers of patients in real world clinical practice.”

Posted in Cronaca/News, Medicina/Medicine/Health/Science | Contrassegnato da tag: , , | Leave a Comment »